BDULF (Bangkok Dusit Medical Services PCL) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BDULF Bangkok Dusit Medical Services PCL BDULF
68 GF Score
Price $0.56
GF Value $0.97
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bangkok Dusit Medical Services PCL Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Bangkok Dusit Medical Services PCL Quality Rank Related Terms

BDULF
68GF Score
Bangkok Dusit Medical Services PCL BDULF
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bangkok Dusit Medical Services PCL (BDULF) Overvalued in 2026?

Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued. The current stock price of $0.56 is trading 42.3% below its estimated GF Value™ of $0.97. GuruFocus considers Bangkok Dusit Medical Services PCL to be Significantly Undervalued.

Key valuation signals for BDULF:

  • Quality Rank:
  • GF Value™: $0.97 vs. price of $0.56 (42.3% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the BDULF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bangkok Dusit Medical Services PCL Business Description

Address New Petchburi Road, 2, Soi Soonvijai 7, Bang Kapi, Huaykwang, Bangkok, THA, 10310
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
68GF Score

Get the complete analysis for BDULF

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$0.97
GF Value